(Q35611919)

English

A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG

scientific article published on 6 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Caroline Seynaeve

13

object named as

C Seynaeve

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

C H Smorenburg

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

S M de Groot

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

A E van Leeuwen-Stok

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

M E Hamaker

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

A N Wymenga

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

H de Graaf

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

F E de Jongh

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

J J Braun

8

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

M Los

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

E Maartense

10

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

H van Tinteren

11

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

J W R Nortier

12

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

6 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

599-605

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433520

27 July 2018

End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433520

27 July 2018

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433520

27 July 2018

Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433520

27 July 2018

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433520

27 July 2018

Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433520

27 July 2018

Chemotherapy treatment for older women with metastatic breast cancer: what is the evidence?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433520

27 July 2018

Cytotoxic therapy for the elderly with metastatic breast cancer: a review on safety, pharmacokinetics and efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433520

27 July 2018

1st International consensus guidelines for advanced breast cancer (ABC 1).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT588

21 January 2018

Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT588

21 January 2018

Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT588

21 January 2018

Moderate dose capecitabine in older patients with metastatic breast cancer: a standard option for first line treatment?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT588

21 January 2018

Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: novel treatment predictive factors identified.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433520

25 September 2018

First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433520

25 September 2018

Dealing with metastatic breast cancer in elderly women: results from a French study on a large cohort carried out by the 'Observatory on Elderly Patients'

1 reference

https://pubmed.ncbi.nlm.nih.gov/24504445

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx) in the treatment of elderly patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24504445

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of docetaxel therapy in elderly (≥70 years) castration resistant prostate cancer patients enrolled in the Netherlands Prostate Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24504445

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/ANNONC/MDT588

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35611919&oldid=1861461990"